Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 7.24% |
GILEAD SCIENCES, INC. | GILD | 4.20% |
ALNYLAM PHARMACEUTICALS | ALNY | 4.12% |
AMGEN INC. | AMGN | 4.06% |
REGENERON PHARMACEUTICALS | REGN | 3.44% |
VERTEX PHARMACEUTICALS | VRTX | 3.22% |
CORTEVA INC | CTVA | 3.12% |
INSMED INC | INSM | 2.73% |
BEONE MEDICINES LTD-ADR | BGNE | 2.47% |
UNITED THERAPEUTICS CORP | UTHR | 2.17% |
ASTRAZENECA PLC ADR | AZN | 2.17% |
BIOGEN IDEC, INC. | BIIB | 2.09% |
NATERA INC | NTRA | 2.08% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.88% |
IONIS PHARMACEUTICALS, IN | IONS | 1.80% |
INCYTE CORP | INCY | 1.73% |
ILLUMINA INC | ILMN | 1.72% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.71% |
HALOZYME THERAPEUTICS INC | HALO | 1.58% |
ARGENX SE - ADR | ARGX | 1.55% |
VIATRIS INC | VTRS | 1.54% |
MEDPACE HOLDINGS | MEDP | 1.51% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.50% |
BRIDGEBIO PHARMA INC | BBIO | 1.44% |
EXACT SCIENCES | EXAS | 1.39% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.35% |
CRISPR THERAPEUTICS AG | CRSP | 1.34% |
EXELIXIS, INC. | EXEL | 1.34% |
REVOLUTION MEDICINES INC | RVMD | 1.30% |
CYTOKINETICS INC | CYTK | 1.30% |
GUARDANT HEALTH INC | GH | 1.18% |
AVIDITY BIOSCIENCES INC | RNA | 1.16% |
MODERNA INC | MRNA | 1.15% |
ROIVANT SCIENCES LTD | ROIV | 1.14% |
ARROWHEAD PHARMACEUTICALS | ARWR | 1.11% |
PTC THERAPEUTICS | PTCT | 1.04% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.97% |
BIONTECH SE-ADR | BNTX | 0.96% |
ALKERMES PLC | ALKS | 0.94% |
TG THERAPEUTICS | TGTX | 0.86% |
PROTAGONIST THER | PTGX | 0.84% |
VAXCYTE INC | PCVX | 0.83% |
AXSOME THERAPEUT | AXSM | 0.82% |
APELLIS PHARMACE | APLS | 0.82% |
AMICUS THERAPEUTICS INC | FOLD | 0.77% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.77% |
VERACYTE INC | VCYT | 0.73% |
ADMA BIOLOGICS INC | ADMA | 0.73% |
MADRIGAL PHARMAC | MDGL | 0.73% |
AKERO THERAPEUTICS INC | AKRO | 0.70% |
CRINETICS PHARMACEUTICALS | CRNX | 0.69% |
BEAM THERAPEUTICS INC | BEAM | 0.66% |
VIKING THERAPEUTICS INC | VKTX | 0.66% |
IDEAYA BIOSCIENCES INC | IDYA | 0.65% |
KRYSTAL BIOTECH INC | KRYS | 0.64% |
NUVALENT INC-A | NUVL | 0.63% |
AGIOS PHARMACEUT | AGIO | 0.63% |
CELLDEX THERAPEUTICS INC | CLDX | 0.61% |
ULTRAGENYX PHARM | RARE | 0.60% |
ASCENDIS PHA-ADR | ASND | 0.60% |
ARCELLX INC | ACLX | 0.59% |
RECURSION PHARMACEUTICALS | RXRX | 0.57% |
INTELLIA THERAPE | NTLA | 0.54% |
DENALI THERAPEUT | DNLI | 0.53% |
SUMMIT THERAPEUTICS INC | SMMT | 0.51% |
NOVAVAX INC | NVAX | 0.50% |
DYNE THERAPEUTICS INC | DYN | 0.47% |
IMMUNOVANT INC | IMVT | 0.46% |
TWIST BIOSCIENCE CORP | TWST | 0.46% |
DYNAVAX TECHNOLOGY | DVAX | 0.43% |
SAREPTA THERAPEU | SRPT | 0.38% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.24% |
GERON CORP | GERN | 0.17% |
Other (Cash, derivatives and other liabilities) | 0.44% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.